|
1
|
Bagga S, Bracht J, Hunter S, et al:
Regulation by let-7 and lin-4 miRNAs results in target mRNA
degradation. Cell. 122:553–563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: microRNAs: tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bracken CP, Gregory PA, Khew-Goodall Y and
Goodall GJ: The role of microRNAs in metastasis and
epithelial-mesenchymal transition. Cell Mol Life Sci. 66:1682–1699.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bracken CP, Gregory PA, Kolesnikoff N, et
al: A double-negative feedback loop between ZEB1-SIP1 and the
microRNA-200 family regulates epithelial-mesenchymal transition.
Cancer Res. 68:7846–7854. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hur K, Toiyama Y, Takahashi M, et al:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. Jul 10–2012.(Epub ahead
of print).
|
|
9
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Christoffersen NR, Silahtaroglu A, Orom
UA, Kauppinen S and Lund AH: miR-200b mediates post-transcriptional
repression of ZFHX1B. RNA. 13:1172–1178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hurteau GJ, Carlson JA, Spivack SD and
Brock GJ: Overexpression of the microRNA hsa-miR-200c leads to
reduced expression of transcription factor 8 and increased
expression of E-cadherin. Cancer Res. 67:7972–7976. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mongroo PS and Rustgi AK: The role of the
miR-200 family in epithelial-mesenchymal transition. Cancer Biol
Ther. 10:219–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gottardo F, Liu CG, Ferracin M, et al:
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
White NM and Yousef GM: MicroRNAs:
exploring a new dimension in the pathogenesis of kidney cancer. BMC
Med. 8:652010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saiki I, Naito S, Yoneda J, Azuma I, Price
JE and Fidler IJ: Characterization of the invasive and metastatic
phenotype in human renal cell carcinoma. Clin Exp Metastasis.
9:551–566. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Williams RD, Elliott AY, Stein N and
Fraley EE: In vitro cultivation of human renal cell cancer. II
Characterization of cell lines. In Vitro. 14:779–786. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen ML, Liang LS and Wang XK: miR-200c
inhibits invasion and migration in human colon cancer cells
SW480/620 by targeting ZEB1. Clin Exp Metastasis. 29:457–469. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burk U, Schubert J, Wellner U, et al: A
reciprocal repression between ZEB1 and members of the miR-200
family promotes EMT and invasion in cancer cells. EMBO Rep.
9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grille SJ, Bellacosa A, Upson J, et al:
The protein kinase Akt induces epithelial mesenchymal transition
and promotes enhanced motility and invasiveness of squamous cell
carcinoma lines. Cancer Res. 63:2172–2178. 2003.PubMed/NCBI
|
|
21
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005.
|
|
22
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hurteau GJ, Carlson JA, Roos E and Brock
GJ: Stable expression of miR-200c alone is sufficient to regulate
TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle.
8:2064–2069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmad A, Aboukameel A, Kong D, et al:
Phosphoglucose isomerase/autocrine motility factor mediates
epithelial-mesenchymal transition regulated by miR-200 in breast
cancer cells. Cancer Res. 71:3400–3409. 2011. View Article : Google Scholar
|
|
25
|
Elson-Schwab I, Lorentzen A and Marshall
CJ: MicroRNA-200 family members differentially regulate
morphological plasticity and mode of melanoma cell invasion. PLoS
One. 5:e131762010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu J, Ohuchida K, Mizumoto K, et al:
MicroRNA, hsa-miR-200c, is an independent prognostic factor in
pancreatic cancer and its upregulation inhibits pancreatic cancer
invasion but increases cell proliferation. Mol Cancer. 9:1692010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakada C, Matsuura K, Tsukamoto Y, et al:
Genome-wide microRNA expression profiling in renal cell carcinoma:
significant down-regulation of miR-141 and miR-200c. J Pathol.
216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang Y and Massague J:
Epithelial-mesenchymal transitions: twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thiery JP and Morgan M: Breast cancer
progression with a Twist. Nat Med. 10:777–778. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
TargetScanHuman release 6.2. Available at:
http://www.targetscan.org.
Accessed Sep 1 2012
|
|
31
|
Porta C and Figlin RA:
Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney
cancer, and the therapeutic potential of
phosphatidylinositol-3-kinase/Akt inhibitors. J Urol.
182:2569–2577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Testa JR and Bellacosa A: AKT plays a
central role in tumorigenesis. Proc Natl Acad Sci USA.
98:10983–10985. 2001. View Article : Google Scholar : PubMed/NCBI
|
